MR

Michael Raven

Chief Executive Officer

IntelGenx Corp.


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
IntelGenx Corp.
Industry
pharmaceuticals
Employees
33.0
Seniority
C suite
Annual Revenue
1051000.0

Technologies

Outlook Webflow Salesforce Nginx Google translate widget Multilingual Mobile Friendly Google Analytics Google Font API Google translate API ON24 Bootstrap Framework Google Tag Manager Remote AI

Keywords

oral thin film oral strip research development manufacturing technology transfer scaleup odf oral dissolvable film licensing contract manufacturing cmo formulation supply transdermal strip cdmo contract development pharmaceutical manufacturing pharmaceutical films oral thin films transdermal patches drug delivery buccal films sublingual films rapid disintegration improved absorption clinical monitoring regulatory support manufacturing scale-up commercial manufacturing analytical development third-party testing patient compliance mucoadhesive drugs extended release drug administration patient benefits drug formulation r&d services state-of-the-art facility innovative product pipeline pharmaceutical services supply chain management partnership opportunities therapeutic conditions oral topical films acute migraine treatment nausea relief potential side effects pediatric formulations geriatric patients bioavailability improvement choking hazard prevention pleasurable taste easy administration individual packaging transportability next generation products comprehensive pharmaceuticals clinical trial support scale-up expertise patient-centric designs fast delivery technology drug performance improvement unmet medical needs safety features clinical efficacy mechanical or industrial engineering pharmaceuticals medical logistics & supply chain

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans